Compare Global X Autonomous & Electric Vehicles (DRIV) vs GE HealthCare Technologies Inc. Common Stock (GEHC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Global X Autonomous & Electric Vehicles vs GE HealthCare Technologies Inc. Common Stock — how do they compare? Global X Autonomous & Electric Vehicles trades at $30.99 (market cap $357.19M), while GE HealthCare Technologies Inc. Common Stock trades at $68.6 (market cap $30.93B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 86.6× Global X Autonomous & Electric Vehicles's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while Global X Autonomous & Electric Vehicles pays none. Which is the better fit depends on your goals.
| DRIV | GEHC | |
|---|---|---|
Market Cap | $357.19M | $30.93B |
Volume | 16,483 | 5,033,451 |
Sector | Sector/Thematic | Health |
52-Week High | $42.53 | $88.16 |
52-Week Low | $27.60 | $59.48 |
Typical Hold Time | 41 Days | — |
Enterprise Value | — | $39.39B |
Dividend Yield | — | 0.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DRIV trades at $32.06, down slightly by 0.06% today. Technical indicators show mixed signals with a bullish overall signal but bearish moving averages. The stock faces resistance at $34 with support at $33. Recent news highlights automotive sector dynamics including hybrid vehicle growth and China's EV ambitions, which could impact DRIV's market positioning.
The outlook for DRIV is cautiously optimistic given sector tailwinds from hybrid and EV adoption, though key financial ratios remain unavailable for fundamental assessment. Risks include oil price volatility and competitive pressures. Analyst sentiment appears balanced with equal buy/sell technical signals, suggesting investors should monitor upcoming earnings for clearer direction.
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Global X Autonomous & Electric Vehicles
DRIV invests in companies involved in autonomous driving and electric vehicle production. It tracks the Solactive Autonomous & Electric Vehicles Index, focusing on software and hardware leaders like Tesla, NVIDIA, and Microsoft.
Read more on DRIV →About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →
